Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tezepelumab Trial Meets Primary Endpoint

americanpharmaceuticalreviewNovember 20, 2020

Tag: Tezepelumab , Asthma , Amgen , AstraZeneca , Navigator

PharmaSources Customer Service